View this article online at www.insightplus.mja.com.au
Clinicians need to be aware of the growing grey market of injectable peptide-based substances being promoted online for weight loss.
Sarah* is 34, works in administration, and has spent two years without a diagnosis. Her symptoms began with cognitive episodes — words vanishing from her screen mid-sentence and memory lapses — followed by functional seizures and right-sided weakness requiring emergency department care. CT scans and an MRI were unremarkable. She was variously labelled with migraine and anxiety and referred back to her GP. Patients like Sarah are common, yet our health system offers no clear pathway for their care.
The Healthy Start for Young Hearts Alliance brings together experts across public health and clinical care with the aim to prevent cardiovascular disease before it begins.
Australia has made significant advances in the prevention of cervical cancer, but progress on other gynaecological cancers is falling behind.
Syphilis cases are on the rise, and inconsistent screening in general practice is leaving people at risk.
New clinical practice guidelines represent a major step in supporting safe and appropriate use of medicines in older people
Low back pain is the leading cause of disability worldwide and Australia is no exception. Around 4 million Australians live with back pain and it is one of the most common reasons people see their GP or physiotherapist. The personal toll from chronic low back pain is significant and so too is the system impact with billions spent each year on health care and lost through reduced workplace productivity or early retirement.
In sweeping reforms to the National Disability Insurance Scheme (NDIS) announced today, the government will cut 160,000 participants from the scheme over the next four years and reduce funding for the average plan by A$5,000 in the next two years.
The Australian Health Biobank is Australia’s first national general population biobank. It provides an unprecedented opportunity to capture population-level trends in disease states and/or environmental exposures, and accelerate integration of scientific discoveries into policy, clinical practice, and future health innovations.
